Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

NCT ID: NCT05991453

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

13000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-13

Study Completion Date

2028-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will conduct a 13,000-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery-Complications Anesthesia Complication Anesthesia Awareness Anesthesia Surgery Quality of Life Pain, Postoperative Anesthesia Morbidity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Propofol total intravenous anesthesia (TIVA)

No administration of inhaled agent.

Group Type ACTIVE_COMPARATOR

Anesthetic technique Propofol TIVA

Intervention Type OTHER

Propofol TIVA no inhaled agent

inhaled volatile general anesthesia (INVA)

Must administer inhaled agent.

Group Type ACTIVE_COMPARATOR

Anesthetic technique inhaled agent

Intervention Type OTHER

Must administer inhaled agent.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anesthetic technique Propofol TIVA

Propofol TIVA no inhaled agent

Intervention Type OTHER

Anesthetic technique inhaled agent

Must administer inhaled agent.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Propofol TIVA Inhaled agent

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Each patient must meet all of the following criteria:

1. Aged 18 years or older
2. Undergoing elective non-cardiac surgery expected to last ≥ 60 min requiring general anesthesia with a tracheal tube or laryngeal mask airway (or similar supra-glottic device)

Exclusion Criteria

Patients will not be enrolled if any of the following criteria are met:

1. Inability to provide informed consent in English (at all study sites) or Spanish (at sites where Spanish consent is provided as an option)
2. Pregnancy (based on patient report or positive test on the day of surgery)
3. Surgical procedure requiring general, regional, neuraxial anesthesia administered by an anesthesia clinician (anesthesiologist, CRNA, anesthesiology assistant) occurring within 30 days prior to or planned to occur within 30 days after surgery date
4. Contraindication to propofol TIVA or INVA (for example, documented allergy to propofol, history of severe postoperative nausea or vomiting, concern for or history of malignant hyperthermia) based on self-report
5. Surgical procedures requiring a specific general anesthesia technique (for example, TIVA required for neuromonitoring).
6. Locally approved, written protocol mandating a particular anesthetic technique
7. History of possible or definite intraoperative awareness during general anesthesia based on patient self-report
8. Planned postoperative intubation
9. Current incarceration
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Patient-Centered Outcomes Research Institute

OTHER

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Avidan

Professor of Anesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sachin Kheterpal, MD

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Michael S Avidan, MBBCh

Role: PRINCIPAL_INVESTIGATOR

Washington University School of Medicine

Allison Janda, MD

Role: STUDY_DIRECTOR

University of Michigan

Mark Neuman, MD

Role: STUDY_DIRECTOR

University of Pennsylvania

Bethany Pennington, PharmD

Role: STUDY_DIRECTOR

Washington University School of Medicine

Douglas Colquhoun, MBChB

Role: STUDY_DIRECTOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arkansas for Medical Sciences (UAMS)

Little Rock, Arkansas, United States

Site Status RECRUITING

University of California San Francisco

San Francisco, California, United States

Site Status RECRUITING

Stanford University

Stanford, California, United States

Site Status NOT_YET_RECRUITING

Yale School of Medicine

New Haven, Connecticut, United States

Site Status RECRUITING

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status RECRUITING

Brigham & Women's

Boston, Massachusetts, United States

Site Status RECRUITING

University of Michigan

Ann Arbor, Michigan, United States

Site Status RECRUITING

Henry Ford Health

Detroit, Michigan, United States

Site Status RECRUITING

Washington University School of Medicine

St Louis, Missouri, United States

Site Status RECRUITING

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status RECRUITING

NYU Langone

New York, New York, United States

Site Status RECRUITING

Weill Cornell Medicine

New York, New York, United States

Site Status RECRUITING

Duke University

Durham, North Carolina, United States

Site Status RECRUITING

Wake Forest

Winston-Salem, North Carolina, United States

Site Status RECRUITING

Oregon Health and Sciences University

Portland, Oregon, United States

Site Status RECRUITING

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status NOT_YET_RECRUITING

University of Texas - MD Anderson

Houston, Texas, United States

Site Status RECRUITING

University of Utah - Medical

Salt Lake City, Utah, United States

Site Status RECRUITING

UVA Health

Charlottesville, Virginia, United States

Site Status RECRUITING

University of Washington

Seattle, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laura Swisher

Role: CONTACT

314-286-1024

Sherry McKinnon

Role: CONTACT

314-286-1024

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Geoffrey Muller, MD

Role: primary

Gwendolyn Cobbs Cobbs

Role: backup

Lee-lynn Chen, MD

Role: primary

Neil Panchal

Role: backup

David Drover, MD

Role: primary

Samantha Gaston

Role: backup

Jaime B Hyman, MD

Role: primary

Andrew Shapiro

Role: backup

Amit Bardia, MD

Role: primary

Ariel Mueller, MA

Role: backup

Luigino Nascimben, MD

Role: primary

Sula Nasra

Role: backup

Allison Janda, MD

Role: primary

Rachel Shoemake

Role: backup

Anoop Chhina, MD

Role: primary

Katherine Nowak, PhD

Role: backup

Laura Swisher

Role: primary

Sherry McKinnon, MS

Role: backup

Stacie Deiner, MD

Role: primary

Simon Tom, MD

Role: primary

Lola Franco

Role: backup

Kane O Pryor, MD

Role: primary

Jay Sangwan

Role: backup

Kam Ghadimi, MD

Role: primary

Kelly Rodden, BSN

Role: backup

Ashish Khanna, MD

Role: primary

Amelia Eaton

Role: backup

Michael Aziz, MD

Role: primary

Sarah Feller

Role: backup

Caoimhe Duffy, MD

Role: primary

Karah Whatley

Role: backup

Juan Cata, MD

Role: primary

Paloma Aveni Strafile, MD

Role: backup

Ken Johnson, MD

Role: primary

Anne Mackey, MD

Role: backup

Bhiken Naik, MD

Role: primary

Keita Ikeda, PhD

Role: backup

Karen Domino, MD

Role: primary

Shawn Mincer

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Tellor Pennington BR, Janda AM, Colquhoun DA, Neuman MD, Kidwell KM, Spino C, Thelen-Perry S, Krambrink A, Huang S, Ignacio R, Wu Z, Swisher L, Cloyd C, Vaughn MT, Pescatore NA, Bollini ML, Mashour GA, Hassett A, Kent CD, Vlisides PE, Avidan MS, Kheterpal S; ˠTHRIVE Research Group. Trajectories of Recovery after Intravenous propofol versus inhaled VolatilE anaesthesia (THRIVE) randomised controlled trial in the USA: A protocol. BMJ Open. 2025 Sep 14;15(9):e103836. doi: 10.1136/bmjopen-2025-103836.

Reference Type DERIVED
PMID: 40953862 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202304082

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.